This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through September 7, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
by Zacks Equity Research
Dexcom sees room to expand CGM adoption as low awareness, reimbursement hurdles and rising GLP-1 use create new opportunities in Type 2 diabetes.
DXCMNegative Net Change ABTPositive Net Change NVONegative Net Change MMEDPositive Net Change
medical medical-devices
Solana Company (HSDT) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HSDTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can ISRG Offset China Weakness With Expansion in India and Japan?
by Indrajit Bandyopadhyay
Intuitive Surgical sees strong growth in India and improving conditions in Japan helping offset China headwinds as international da Vinci procedures rise 20%.
ISRGNegative Net Change BSXNegative Net Change MDTNegative Net Change
medical medical-devices
QIAGEN Expands US QIAstat-Dx Portfolio With New FDA-Cleared Panel
by Zacks Equity Research
QGEN expands its U.S. QIAstat-Dx portfolio with an FDA-cleared panel that detects gram-negative bacteria and resistance markers in about one hour.
QGENPositive Net Change BDXNegative Net Change TMOPositive Net Change BRKRPositive Net Change
medical medical-devices
5 Medical Dental Supply Stocks to Watch as Industry Prospects Improve
by Indrajit Bandyopadhyay
Here, we highlight five medical supplies stocks, MCK, CAH, BDX, MMSI and PDEX, with strong potential that investors should keep on their watchlist amid improving industry prospects.
MCKPositive Net Change BDXNegative Net Change CAHNegative Net Change MMSINegative Net Change PDEXNegative Net Change
medical medical-devices
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
by Zacks Equity Research
NEOG's 83% YTD rally reflects Food Safety momentum, Petrifilm expansion, solutions-based selling and a growing product pipeline.
NEOGNegative Net Change GMEDPositive Net Change PAHCPositive Net Change VCYTPositive Net Change
medical medical-devices
Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
by Zacks Equity Research
SNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.
SNNNegative Net Change WSTNegative Net Change GMEDPositive Net Change VCYTPositive Net Change
medical medical-devices
10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises
by Zacks Equity Research
TXG begins Atera shipments as orders top 40 systems, highlighting strong early demand and broad research interest in its spatial biology platform.
TXGPositive Net Change ISRGNegative Net Change GMEDPositive Net Change VCYTPositive Net Change
medical medical-devices
Should You Continue to Hold IART Stock in Your Portfolio?
by Zacks Equity Research
Integra sees steady Specialty Surgery demand and improving efficiency, but leverage and currency swings remain key challenges for Integra.
IARTNegative Net Change GMEDPositive Net Change PAHCPositive Net Change VCYTPositive Net Change
medical medical-devices
Boston Scientific's MedSurg Diversification Bolsters Growth Prospects
by Moumi Mondal
BSX's MedSurg segment supports growth, with Endoscopy and Neuromodulation gains offsetting Urology challenges and portfolio gaps.
BSXNegative Net Change MDTNegative Net Change TFXNegative Net Change
medical medical-devices